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A highly potent secondary metabolite producing endophytic strain, Streptomyces sp.
HUST012 was isolated from the stems of the medicinal plant Dracaena cochinchinensis
Lour. Strain HUST012 showed antimicrobial and antitumor activities which were
significantly much higher than those of dragon’s blood extracted from D. cochinchinensis
Lour. On further analysis, the strain was found to produce two metabolites, SPE-B11.8
(elucidated to be a novel metabolite (Z)-tridec-7-ene-1,2,13-tricarboxylic acid) and
SPE-B5.4 (elucidated as Actinomycin-D). The Minimum Inhibitory Concentration
values of SPE-B11.8 against a set of test bacterial organisms (Methicillin-resistant
Staphylococcus epidermis ATCC 35984, Methicillin-resistant Staphylococcus aureus
ATCC 25923, Escherichia coli ATCC 25922, and Klebsiella pneumoniae ATCC 13883)
ranged between 15.63 and 62.5µg/ml while that for SPE-B5.4 ranged between 0.04
and 2.24µg/ml. The compound SPE-B11.8 showed cytotoxic effect at 41.63 and
29.54µg/ml IC50-values against Hep G2 and MCF-7, respectively, while the compound
SPE-B5.4 exhibited stronger activities against them at 0.23 and 0.18µg/ml IC50-values.
Keywords: endophytic, Streptomyces sp. HUST012, Dracaena cochinchinensis Lour., antimicrobial and cytotoxic
activities, (Z)-tridec-7-ene-1,2,13-tricarboxylic acid, Actinomycin-D
Introduction
Streptomyces spp. have been shown to possess the ability to synthesize antibacterial, antifungal,
insecticidal, antitumor, anti-inflammatory, anti-parasitic, antiviral, anti-infective, antioxidant, and
herbicidal compounds (Qin et al., 2011; Kawahara et al., 2012). Nearly 70% of the natural antibiotics
used in clinical practices were produced by actinobacteria (Subramani and Aalbersberg, 2012) of
Khieu et al. Antimicrobial and cytotoxic effects of Streptomyces sp. HUST012
which 75–80% have been derived from Streptomyces alone (Inbar
and Lapidot, 1988; Olano et al., 2004; Rehm et al., 2009; Crnovcic
et al., 2013).
The plant Dracaena cochinchinensis Lour. has been used as a
traditional medicine since ancient times in the form of Dragon’s
blood, a deep red resin. Dragon’s blood has been shown to
illustrate antimicrobial, antiviral, antitumor, cytotoxic, analgesic,
antioxidative, anti-inflammatory, haemostatic, antidiuretic, anti-
ulcer and wound healing activities (Gupta et al., 2008). It
also finds application as coloring materials and wood varnish
(Gupta et al., 2008). However, the slow growth in combination
with its low dragon’s blood yield results in the destruction
of large number of century old plant for harvesting a few
milligrams of dragon’s blood (Fan et al., 2008). This current
study was conducted to explore a sustainable way of utilizing
the medicinal plant by studying the endophytic actinomycetes
associated with the plant. This paper incorporated the results
of the characterization and the evaluation of cytotoxic and
antimicrobial effects of an endophytic Streptomyces sp. strain,
isolated from the medicinal plant D. cochinchinensis Lour. in
comparison with those of dragon’s blood extracted from the
host plant. The paper also reported the structure elucidation
of the bioactive metabolites extracted from the endophytic
actinobacteria.
Materials and Methods
Sample Collection and Isolation of Endophytic
Actinomycete
Healthy stems of D. cochinchinensis Lour. plant were collected
from Cuc Phuong National Park, Ninh Binh province, Vietnam
(20◦ 19′ 8′′N, 105◦ 37′ 20′′E; 338m). The samples were surface
sterilized and plated on Sodium propionate medium (Qin et al.,
2009). The medium was supplemented with nalidixic acid (25
mg/l), nystatin (50 mg/l), and K2Cr2O7 (50mg/l) to inhibit
the growth of Gram-negative bacteria and fungi and polyvinyl
pyrolidone (PVP) 2% and tannase 0.005% to improve the
growth of colonies. Actinomycetes colonies grown on this culture
media were selected and purified by repeated streaking onto
International Streptomyces Project (ISP) 2 medium. The purified
strain HUST012 was preserved as glycerol suspensions (20%, v/v)
and as lyophilized spore suspensions in skim milk at −80◦C
(Zhang et al., 2010).
Characterization of the Endophytic Isolate
HUST012
The endophytic isolate HUST012 was characterized on the basis
of the physiological and biochemical properties and the analysis
of 16S rRNA gene sequence. Morphological and growth patterns
were observed on different media (Shirling and Gottlieb, 1966).
Morphological characteristics were observed by light microscopy
(Olympus BH2) and scanning electronmicroscopy (JSM-6610LV,
JEOL Ltd.) (Anderson and Wellington, 2001). The ability of the
isolate to grow at different pH (4.0–10.0, at intervals of 1.0 pH
unit using the buffer system as described by Xu et al., 2005)
and concentration of NaCl (0, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0,
10.0, 11.0, 12.0, 15.0%, w/v) was examined on ISP 2 medium.
Growth was tested at 4, 10, 20, 25, 28, 37, 45, and 55◦C using ISP2
medium. The hydrolysis of starch, casein and gelatin was carried
out according to the methods described by Tindall et al. (2007).
Nitrate reduction and H2S production were determined using
conventional procedures (Goodfellow, 1971; Athalye et al., 1985).
Utilization of the carbon source was performed as previously
described (Shirling and Gottlieb, 1966; Athalye et al., 1985;
Mechri et al., 2014) using the basal medium recommended by
Pridham and Gottlieb (1948).
The isolation of genomic DNA and PCR amplification for
16S rRNA gene was performed as previously described (Li
et al., 2009). The identification of phylogenetic neighbors and
calculation of pairwise 16S rRNA gene sequence similarities were
achieved using the EzTaxon server (http://www.eztaxon.org/)
(Kim et al., 2012) and BLAST analysis (http://blast.ncbi.nlm.
nihgov/Blast.cgi). Multiple sequence alignment was done using
CLUSTALW (Thompson et al., 1997). The phylogenetic tree was
constructed using the aligned sequences by the neighbor-joining
method (Saitou and Nei, 1987) using Kimura-2-parameter
distances (Kimura, 1983) in the MEGA 6 software (Tamura et al.,
2013). To determine the support of each clade, bootstrap analysis
was performed with 1000 replications (Felsenstein, 1985).
The GenBank accession number for the partial 16S rRNA gene
sequences of strain HUST012 is KP330557.
Evaluation of Antimicrobial Activities
The antibacterial activities was evaluated against Methicillin-
susceptible Staphylococcus aureus (MSSA) ATCC 29213,
Methicillin-resistant Staphylococcus epidermidis (MRSE) ATCC
35984, Methicillin-resistant Staphylococcus aureus (MRSA)
ATCC 25923, Klebsiella pneumoniae ATCC 13883, Aeromonas
hydrophilaATCC 7966, Escherichia coliATCC 25922, Escherichia
coli ATCC 11105, and Enterococcus faecalis ATCC 29212 using
the agar well diffusion method (Holder and Boyce, 1994). The
Minimum Inhibitory Concentration (MIC) was determined as
previously described (Andrews, 2001).
The animal fungal pathogens Fusarium graminearum,
Aspergillus carbonarius, and Aspergillus westerdijkiae which
were known to produce strong toxic deoxynivalenol (DON)
and ochratoxin A (Khamna et al., 2009; Huffman et al., 2010)
were kindly provided by UMR Qualisud, CIRAD, France.
These strains were maintained on Potato Dextrose Agar (PDA)
medium (Liu et al., 2002). For the determination of antifungal
activity, culture broth of HUST012 (100ml) was centrifuged
at 7000 g for 10min. The supernatant was collected and added
to the PDA medium (pH 5.5) at a concentration of 15% (v/v).
Sterilized water was used as control. The resulting PDA plates
were inoculated with the different fungal strains and incubated
for 5 days at 28◦C. The fungal radial growth was measured. Each
experiment was carried out in triplicates.
Determination of Cytotoxic Activity
The cytotoxicity against human hepatocellular carcinoma Hep
G2 and human breast adenocarcinoma MCF-7 cell lines was
tested by using sulforhodamine B (SRB) assay as previously
described (Thao et al., 2014). Ellipcitine was used as the positive
control. The test was done in triplicates to ensure accuracy.
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Fermentation
A small-scale liquid fermentation was performed with YIM 61
medium (Qin et al., 2009) as the antibiotic producing medium
(200 rpm, 28◦C, 5 days). The scale up fermentation (20 L)
was done using the New Brunswick BioFlo R©/CelliGen R© 115
Benchtop Fermentor & Bioreactor (28◦C, 5 days). In both cases,
seed culture for inoculation was prepared in ISP2 medium
(200 rpm, 28◦C, 4 days)
Extraction and Purification of the Active
Compounds
The fermentation broth was centrifuged at 7000 rpm for 10min.
The supernatant fraction was then extracted thrice with ethyl
acetate. The ethyl acetate layer was concentrated in vacuo to give
ethyl acetate extract (SPA-E). The aqueous phase was filtered
through a diaion HP20 column and eluted with water and
methanol subsequently. The water eluent fraction was evaporated
to give the extract designated as SPA-W1 while the methanol
eluent was concentrated in vacuo to obtain a brown solid
(SPA-W2).
Similarly, the mycelium cake obtained after centrifugation
of the fermentation broth was processed to obtain a ethyl-
acetate extract (SPB-E), a water eluent extract (EPB-W1) and
a methanol eluent extract (SPB-W1). All these fractions were
analyzed in Silica gel TLC sheet (Merck, Germany) using the
dichloromethane-methanol (30:1, v/v) solvent system. Based on
the similarity profiles in the TLC (Koup et al., 1978), SPA-E/SPB-
E, SPA-W1/SPB-W1, and SPA-W2/SPB-W2were pooled together
and were designated as SP-E, SP-W1, and SP-W2, respectively.
A schematic diagram representing the extraction protocol is
shown in Figure 1. Each of these fractions was evaluated for
antimicrobial and cytotoxic activities. The bioactive fractions
were further purified using different solvent systems to obtain
pure metabolite(s) as represented in Figure 1B.
Structure Elucidation of the Pure Active
Compounds
The structure of the bioactive compound(s) was analyzed using
mass spectrometry (MS) and nuclear magnetic resonance (NMR)
spectroscopy (Booth et al., 1976; Hamza et al., 2013). The results
were compared with the available reference compounds and
published literatures.
Determination of Antibacterial and Cytotoxic
Effects of the Dragon’s Blood Extracted from
Medicinal Plant D. cochinchinensis
Dragon’s blood in the xylem of the host plant was extracted
as described by Wang et al. (2011). The dry weight of the
extract was dissolved in 95% (v/v) alcohol and filtered through
sterile filter membrane (0.22µm). The solution was then used for
antibacterial and antitumor tests.
The MIC of Dragon’s blood against MSSA ATCC 29213,
MRSE ATCC 35984, K. pneumoniae ATCC 13883, and E. coli
ATCC 25922 was determined by broth dilution method on 96-
well plate as previously described (Andrews, 2001). The MIC
against F. graminearum was determined according to Gopal et al.
(2012). The SRB assay was used for determination the cytotoxic
effect of the Dragon’s blood on human breast adenocarcinoma
(MCF-7) and human hepatocellular carcinoma (Hep G2) cells
(Thao et al., 2014).
Results
Characterization of Strain HUST012
Cells of the strain HUST012 was Gram-positive and aerobic. The
strain formed extensively branched, non-fragmented substrate
and aerial mycelia. Strain HUST012 formed straight or
rectiflexibile spore chains with smooth surface. However, these
spore chains generally contained less than 50 spores (Figure
S1). The strain grew well on ISP 2, ISP 3, ISP 5, TSA, Czapek,
and Nutrient agar media, with a gray color aerial mycelium. It
produced green-yellow and yellow pigments on ISP2 and Czapek
agar media respectively. Strain HUST012 was found to grow over
a wide range of temperature (4–45◦C) and pH (4.0–9.0) with
optimal growth at 28◦C and pH 6.0–7.0, and in the presence of
upto 10% NaCl (w/v) with optimum at 1–3% NaCl.
HUST012 could utilize DL-alanine, L-arginine, L-asparagine,
Glycine, DL-leucine, L-lysine, DL-serine, L-glutamic acid,
DL-methionine, L-cystine, L-histidine as nitrogen resources;
D-fructose, D-galactose, D-glucose, D-mannose, D-trehalose,
D-sorbose, D-xylose, glycerol, and sodium acetate as carbon
sources. The strain was positive for amylase and catalase
activities, but was negative for nitrate reduction, H2S production
and gelatin reduction tests. Strain HUST012 showed highest
16S rRNA gene sequence similarities with Streptomyces parvulus
(99.26%). Phylogenetic tree (Figure 2) based on neighbor-joining
method also indicated its closest similarity to Streptomyces
parvulus. The phenotypic and genomic data indicated that the
strain HUST012 represented a strain of the genus Streptomyces
for which the strain was referred to as Streptomyces sp. strain
HUST012.
Antimicrobial and Cytotoxic Effects of Strain
HUST012
The culture filtrate of strain HUST012 exhibited antibacterial
activity against all tested Gram positive and Gram negative
bacterial strains. The maximum activity was found against MRSE
ATCC 35984 (inhibition zone of 35mm diameter), followed by
A. hydrophila ATCC 7966 (26mm) and MSSA ATCC 29213
(25.80mm). The detailed antimicrobial profiles are shown in
Table 1.
The antifungal activity of Streptomyces sp. strain HUST012
was examined against three mycotoxin producing fungal strains.
The fungal growth inhibition was observed in the order:
F. graminearum (9.7mm), A. carbonarius (7.7mm), and A.
westerdijkiae (1.8mm).
Fermentation, Antimicrobial and Cytotoxic
Effects of Bioactive Metabolites of Strain
HUST012
Among the crude metabolites extracts of strain HUST012, the
fraction SP-E showed the highest antibacterial and cytotoxic
activities. This fraction was further purified by column
chromatography with different gradient solvent systems as
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FIGURE 1 | Schematic representation of the process for
metabolite extraction from strain HUST012. (A) Extraction of
the fermentation medium into crude metabolite extracts; (B)
fractionation protocol for pure compounds SPE-B11.8 and
SPE-B5.4 from the crude ethyl acetate extract. Note: CC,
Column chromatography; Font in red color indicates supernatant,
blue mycelium and green pooled fractions; Color boxes indicate
pure compound.
depicted in Figure 1. Two bioactive metabolites, designated SPE-
B11.8 and SPE-B5.4, were purified.
The MIC values of the metabolite SPE-B11.8 against the test
bacterial organisms ranges between 15.63 and 62.5µg/ml while
those for SPE-B5.4 ranges between 0.04 and 2.24µg/ml (Table 2).
Human hepatocellular carcinoma Hep G2 and human breast
adenocarcinoma cell MCF-7 lines were used as model systems
to examine the cytotoxic effect of Streptomyces sp. HUST012.
The culture filtrate, crude metabolite extracts (SP-E, SP-W1, SP-
W2) and the pure metabolites (SPE-B11.8 and SPE-B5.4) were
examined for their cytotoxic effect on the two human cancer cell
lines Hep G2 and MCF-7. The cytotoxic assay results showed
that the culture filtrate of the strain HUST012 had significant
inhibition toward Hep G2 and MCF-7 cells with IC50-values of 4
and 3µg/ml, respectively. Among the crude metabolites extracts,
SP-E showed the strongest cytotoxic effect with IC50-values of
0.31 and 0.18µg/ml. The pure metabolites SPE-B11.8 showed
cytotoxic effect at 41.63 and 29.54µg/ml IC50-values against
Hep G2 and MCF-7, respectively, while the metabolite SPE-B5.4
exhibited the same at 0.23 and 0.18µg/ml IC50-values (Table 3).
Structure Elucidation of Bioactive Compounds
The structure of the compounds SPE-B11.8 and SPE-B5.4 were
analyzed through the techniques of MS and NMR spectroscopy.
The compound SPE-B11.8 was obtained as a colorless solid.
Its HRESIMS spectrum showed a peak atm/z 315.1814 [M+H]+,
corresponding to the molecular formula C16H27O6. The 1D and
2D-NMR spectra of SPE-B11.8 showed signals characteristic
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FIGURE 2 | Neighbor-joining tree showing the phylogenetic relationships based on 16S rRNA gene sequence of the strain HUST012 and closest
species. Bootstrap values (expressed as percentages of 1000 replications) greater than 50% was given at the node.
TABLE 1 | Antimicrobial activities of the strain Streptomyces sp. HUST012
against bacterial and fungal strains.
Test strains Inhibition zone
(mm diameter)
GRAM POSITIVE BACTERIA
Methicillin-resistant S. epidermidis ATCC 35984 35.00 ± 0.80
Methicillin-resistant S. aureus ATCC 25923 18.90 ± 1.67
Methicillin-susceptible S. aureus ATCC 29213 25.80 ± 1.47
Enterococcus faecalis ATCC 29212 20.00 ± 0.20
GRAM NEGATIVE BACTERIA
Escherichia coli ATCC 25922 18.90 ± 1.00
Escherichia coli ATCC 11105 12.40 ± 0.73
Klebsiella pneumoniae ATCC 13883 19.80 ± 2.20
Aeromonas hydrophila ATCC 7966 26.00 ± 0.47
FUNGAL STRAINS
Fusarium graminearum 9.70 ± 0.73
Aspergillus westerdijkiae 1.80 ± 0.47
Aspergillus carbonarius 7.70 ± 0.80
for a monounsaturated fatty acid with the double bond at δH
5.33/δC129.1–129.9, three carboxylic groups at δC 175.1, 178.1,
and 181.1, and a cluster of methylenic protons at δC in the
range of δC 24.6–35.1. The COSY and HMBC spectra led to the
identification of the fragments of SPE-B11.8 structure (see Figure
S2 for the complete NMR spectra). The position of the double
TABLE 2 | Antibacterial and cytotoxic effects of the compounds
HPE-B11.8 and SPE-B5.4 in comparison with Dragon’s blood extracted










15.63 ± 1.18 0.04 ± 0.00 4.88 ± 0.05
MRSA ATCC
25923
62.5 ± 2.26 0.04 ± 0.00 4.88 ± 0.05
E. coli ATCC
25922
Inactive 2.24 ± 0.01 9.77 ± 0.23
K. pneumoniae
ATCC 13883
62.5 ± 2.26 0.04 ± 0.00 4.88 ± 0.05
F. graminearum Inactive 9.77 ± 0.23 19.53 ± 0.80
Hep G2 41.63 ± 0.61 0.23 ± 0.05 77.91 ± 0.22
MCF-7 29.54 ± 2.89 0.18 ± 0.05 70.00 ± 7.08
bond was also confirmed by theMS data with the fragment atm/z
128.08 and 187.08 corresponding to the breakdown at C-7 and C-
8 liason. The configuration of the double bond was determined
based the on the chemical shifts of vicinal carbon atoms. Both
C-6 and C-9 appeared at δC 26.5 and 26.3 ppm indicating the Z
configuration. Thus, compound SPE-B11.8 was newly elucidated
to be (Z)-tridec-7-ene-1,2,13-tricarboxylic acid (Figure 3).
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TABLE 3 | Cytotoxicity of test sample (IC50 in µg/ml).
Samples Hep G2 MCF-7
Culture filtrate of HUST012 4.00 ± 0.10 3.00 ± 0.10
SP-E 0.31 ± 0.03 0.18 ± 0.02
SP-W1 >100 >100
SP-W2 >100 >100
SPE-B11.8 41.63 ± 0.61 29.54 ± 2.89
SPE-B 5.4 0.23 ± 0.05 0.18 ± 0.05
Ellipticine 0.51 ± 0.08 0.47 ± 0.05
FIGURE 3 | Structure of the compound SPE-B11.8 (elucidated as
(Z)-tridec-7-ene-1,2,13-tricarboxylic acid).
The compound SPE-B5.4 was obtained as a red powder,
soluble in methanol, ethyl acetate, ethanol, and DMSO, stable
in aqueous solutions at 5–10◦C. The HRESIMS spectrum
revealed a peak at m/z 1255.6435 [M+H]+, corresponding to
the formula C62H87N12O16 (Figure S3). The
1H-NMR, 13C-
NMR spectrum analysis data of the SPE-B5.4 compound is
presented in Table S1. The spectral data was compared with
the findings of Booth et al. (1976) and the compound SPEB-
5.4 was identified as Actinomycin-D with molecular formula
C62H86N12O16 (Figure 4).
Antibacterial and Cytotoxic Effects of the
Dragon’s Blood Extracted from Medicinal Plant
D. cochinchinensis
The Dragon’s blood extract was analyzed for its antibacterial and
cytotoxic effects against MRSA, MRSE, K. pneumoniae and E.
coli, and toward MCF-7 and Hep G2 cell lines. Table 2 showed
theMIC for the dragon’s blood extracts in comparison with those
of the crude metabolites extracts and the compounds SPE-B11.8
and SPE-B5.4.
Discussion
The antimicrobial resistance has been one of the most serious
health threats. Infections from resistant bacteria are now too
common, and some pathogens have even become resistant to
multiple classes of antibiotics. The decline of effective antibiotics
will undermine our ability to fight infectious diseases andmanage
the infectious complications common in vulnerable patients,
especially those undergoing chemotherapy for cancer, dialysis
for renal failure, and organ transplantation. When first- and
second-line antibiotic treatment options are limited by resistance
and/or unavailability, healthcare providers are forced to use toxic
antibiotics which are frequently more expensive but less effective.
Even when alternative treatments are available, research has
shown that patients with resistant infections are oftenmuchmore
likely to result in death, and that survivors require longer hospital
stays, delayed recuperation, and long-term disability. Hence,
there is an urgent need for search of novel drugs against such
pathogens. It has been envisaged that endophytic environment
is an extreme source to provide exciting new bioactive
compounds.
In the present study, an attempt was tried to identify
the bioactive potential of the endophytic actinobacterium
Streptomyces sp. HUST012. The strain was found to exhibit
antimicrobial activities against a set of pathogenic bacteria and
fungi (Table 1). The presence of antifungal activities is also an
indication of probable biocontrol mechanisms against mycotoxin
producing fungal strains. Similar findings have been reported in
similar studies of Streptomyces strains (Rahman et al., 2010; Usha
et al., 2010; Naine et al., 2015).
The cytotoxic ability of this strain was significant as compared
to that reported in previous studies on S. parvulus strain VITJS11
(Naine et al., 2015). The compounds SPE-B11.8 and SPE-B5.4
had IC50-values of 41.63 and 0.23µg/ml on Hep G2 cells as
compared to 500µg/ml by S. parvulus strain VITJS11. Other
reports showed that migrastatin, a secondary metabolite from
Streptomyces inhibited the Hep G2 cells at the concentration of 6
and 10µM after 24 and 48 h of treatment (Rambabu et al., 2014).
The high bioactive effect of Streptomyces sp. HUST012 can be
explained by the fact that endophytic actinomycetes live in close
association with their host plants and that it could become a real
possibility for exchange of genes involved in natural products
biosynthesis between endophytic actinomycetes and host plants
via horizontal gene transfer, resulting in synthesis of plant-
derived compounds by a microbial endophyte (Chandra et al.,
2013).
An important finding of this current study was the isolation
of the new compound HPE-B11.8 which was elucidated as (Z)-
tridec-7-ene-1,2,13-tricarboxylic acid, thereby underlying the
importance of the source. The compound HPE-B11.8 possessed
moderate antibacterial and anticancer activities against the
test pathogenic microorganisms/cell lines. Another important
finding was the isolation of Actinomycin D (compound SPE-
B5.4). Actinomycin D was an antineoplastic antibiotic that
inhibits cell proliferation. It finds wide range of applications,
viz. as selective reagent in cell culture, studies in suppressing
HIV-replication and programmed cell death of PC12 cells, and
as an antibiotic in treatment of various malignant neoplasm
including Wilm’s tumor and the sarcomas. Actinomycin-D
decreases Mcl-1 expression and acts synergistically with ABT-
737 against small cell lung cancer cell lines (Aishan et al.,
2010). According to the Internet bibliographic database-
MEDLINE, actinomycins, especially Actinomycin-D, have
been the subject of about 3300 research publications (Koba
and Konopa, 2005). The isolation of Actinomycin-D is
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FIGURE 4 | Structure of the compound SPE-B3.4 (established as Actinomycin-D).
not a new discovery but our present study proved that the
medicinal plant D. cochinchinensis Lour. was a rich source
of endophytic actinomycetes producing the potent antibiotic
agents.
Dragon’s blood has been well documented for its
antimicrobial, antioxidant, anti-antitumor and cytotoxic
properties. However, the host plant D. cochinchinensis Lour.
has no secretory tissue to release this useful metabolite, and
therefore Dragon’s blood remains in xylem parenchyma cells
of the stem. The growth of the plant is extremely slow and has
low yield of dragon’s blood. To harvest a few pieces of resinous
wood, a tree with hundreds of years old is often destroyed. This
work aimed to evaluate the antimicrobial and cytotoxic effects
of the natural Dragon’s blood extracted from medicinal plant D.
cochinchinensis Lour. in comparison with that secreted by the
endophytic Streptomyces sp. HUST012 associated with the host
plant. Our results were significant in comparison to the findings
of other research groups (Al-Fatimi et al., 2005; Wang et al.,
2010, 2011). This could give us a suggestion for the promotion
of the application of secondary bioactive metabolites from
endophytic actinomycetes associated with the medicinal plant D.
cochinchinensis Lour. instead of destroying valuable endangered
trees.
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